Abstract
Acta Ophthalmologica ScandinavicaVolume 77, Issue S229 p. 27-28 Free Access Experimental studies of agents with potential neuroprotective properties Larry A. Wheeler, Larry A. Wheeler Allergan, Inc., Department of Biological Sciences, 2525 Dupont Drive, Irvine, CA 92612, USASearch for more papers by this author Larry A. Wheeler, Larry A. Wheeler Allergan, Inc., Department of Biological Sciences, 2525 Dupont Drive, Irvine, CA 92612, USASearch for more papers by this author First published: 13 November 2014 https://doi.org/10.1111/j.1600-0420.1999.tb01133.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References Quigley HA, Nickells RW, Kerrigan LA et al. (1995): Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophth Vis Sci 36: 774– 786. Kerrigan LA, Zack DJ, Quigley HA, Smith SD & Pease ME (1997): TUNEL-positive ganglion cells in human open-angle Glaucoma. Arch Ophthamol 115: 1031– 1035. Nickells RW (1996): Retinal ganglion cell death in glaucoma: The how, the why and the maybe. J Glaucoma 5: 345– 356. Vorwerk CK, Lipton SA, Zurakowski D et al. (1996): Chronic low-dose glutamate is toxic to retinal ganglion cells. Invest Ophth Vis Sci 37(8): 1618– 1624. Dryer EB, Zurakowski D, Schumer RA, Podos SM & Lipton SA (1996): Elevated glutamate in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114: 299– 305. Duvdevani R, Rosner M, Belkin M, Sautter J, Sabel BA & Schwartz M (1990): Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restor Neurol Neurosci 2: 31– 38. Yoles E & Schwartz M (1998): Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol 116: 906– 910. Garcia-Valenzuela E, Shareef S, Walsh J & Sharma SC (1995): Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61(1): 33– 44. Yoles E, Wheeler LA & Schwartz M (1999): Aipha-2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthal V15 Sci; in press. Hicks D, Heidinger V, Mohand-Said S, Sahel J & Dreyfus H (1998): Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia. Gen Pharmacol 30(30): 265– 273. Sievers J, Hausmann B, Unsicker K & Berry M (1987): Fibroblast growth factors promote the survival or adult rat retinal cells after transection of the optic nerve. 76: 157– 162. Peinado-Ramon P, Salvador M, Villegas-Perez MP & Vidat-Sanz M (1996): Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. Invest Ophthalmol Vis Sci 37: 489– 500. Zhang C, Takahasi K, Lam TT & Tso MO (1994): Effects of basic fibroblast growth factor in retinal ischemia. Invest Ophthalmol Vis Sci 35(8): 3163– 3168. Wen R, Cheng T, Li Y, Cao W & Steinberg RH (1996): Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci 16(19): 5986– 5992. Peng M, Yiwen L, Zhijun L, Liu C, Latties A & Wen R (1998): Alpha-2-adrenergic agonists selectively activate extracellular signal-regulated kinases in Mueller cells in vivo. Invest Ophthal Vis Sci 39: 721– 1726. Hasson D, Lai RK, Chun T & Wheeler LA (1997): Functional protection of rat retina ischemic injury by brimonidine, Soc Neuroscience 23: 72– 74. Chao DT & Korsmeyer SJ (1998): Bcl-2 family: regulators of cell death. Ann Rev Immunol 16: 395– 419. Volume77, IssueS229December 1999Pages 27-28 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
